Literature DB >> 30415656

Drug delivery systems for programmed and on-demand release.

Pooya Davoodi1, Lai Yeng Lee2, Qingxing Xu3, Vishnu Sunil1, Yajuan Sun1, Siowling Soh1, Chi-Hwa Wang4.   

Abstract

With the advancement in medical science and understanding the importance of biodistribution and pharmacokinetics of therapeutic agents, modern drug delivery research strives to utilize novel materials and fabrication technologies for the preparation of robust drug delivery systems to combat acute and chronic diseases. Compared to traditional drug carriers, which could only control the release of the agents in a monotonic manner, the new drug carriers are able to provide a precise control over the release time and the quantity of drug introduced into the patient's body. To achieve this goal, scientists have introduced "programmed" and "on-demand" approaches. The former provides delivery systems with a sophisticated architecture to precisely tune the release rate for a definite time period, while the latter includes systems directly controlled by an operator/practitioner, perhaps with a remote device triggering/affecting the implanted or injected drug carrier. Ideally, such devices can determine flexible release pattern and intensify the efficacy of a therapy via controlling time, duration, dosage, and location of drug release in a predictable, repeatable, and reliable manner. This review sheds light on the past and current techniques available for fabricating and remotely controlling drug delivery systems and addresses the application of new technologies (e.g. 3D printing) in this field.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3D printing; Drug delivery systems; Micro-/nano-carriers; On-demand release; Programmed drug delivery

Mesh:

Year:  2018        PMID: 30415656     DOI: 10.1016/j.addr.2018.07.002

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  31 in total

Review 1.  Environmentally responsive hydrogels for repair of cardiovascular tissue.

Authors:  Shuaimeng Guan; Jiankang Li; Kun Zhang; Jingan Li
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

Review 2.  Foundations of gastrointestinal-based drug delivery and future developments.

Authors:  Jacqueline N Chu; Giovanni Traverso
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-16       Impact factor: 46.802

3.  Cascade Drug-Release Strategy for Enhanced Anticancer Therapy.

Authors:  Xu Zhang; Sheng Wang; Guohui Cheng; Peng Yu; Jin Chang; Xiaoyuan Chen
Journal:  Matter       Date:  2021-01-06

Review 4.  Intelligent automated drug administration and therapy: future of healthcare.

Authors:  Richa Sharma; Dhirendra Singh; Prerna Gaur; Deepak Joshi
Journal:  Drug Deliv Transl Res       Date:  2021-01-14       Impact factor: 4.617

Review 5.  Supramolecular coordination complexes as diagnostic and therapeutic agents.

Authors:  Guocan Yu; Meijuan Jiang; Feihe Huang; Xiaoyuan Chen
Journal:  Curr Opin Chem Biol       Date:  2020-10-23       Impact factor: 8.822

Review 6.  Evolution of drug-eluting biomedical implants for sustained drug delivery.

Authors:  Juliana C Quarterman; Sean M Geary; Aliasger K Salem
Journal:  Eur J Pharm Biopharm       Date:  2020-12-16       Impact factor: 5.589

7.  Nanomagnetite-embedded PLGA Spheres for Multipurpose Medical Applications.

Authors:  Valentina Grumezescu; Oana Gherasim; Irina Negut; Stefan Banita; Alina Maria Holban; Paula Florian; Madalina Icriverzi; Gabriel Socol
Journal:  Materials (Basel)       Date:  2019-08-08       Impact factor: 3.623

Review 8.  Core-Shell Fibers: Design, Roles, and Controllable Release Strategies in Tissue Engineering and Drug Delivery.

Authors:  Muhammad Faiq Abdullah; Tamrin Nuge; Andri Andriyana; Bee Chin Ang; Farina Muhamad
Journal:  Polymers (Basel)       Date:  2019-12-04       Impact factor: 4.329

Review 9.  Turning regenerative technologies into treatment to repair myocardial injuries.

Authors:  Felicia Carotenuto; Laura Teodori; Anna Maria Maccari; Luciano Delbono; Giuseppe Orlando; Paolo Di Nardo
Journal:  J Cell Mol Med       Date:  2019-09-30       Impact factor: 5.310

10.  Artificial Inclusion Bodies for Clinical Development.

Authors:  Julieta M Sánchez; Hèctor López-Laguna; Patricia Álamo; Naroa Serna; Alejandro Sánchez-Chardi; Verónica Nolan; Olivia Cano-Garrido; Isolda Casanova; Ugutz Unzueta; Esther Vazquez; Ramon Mangues; Antonio Villaverde
Journal:  Adv Sci (Weinh)       Date:  2019-11-27       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.